These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26990090)

  • 41. Epilepsy with eyelid myoclonia in the setting of de novo pathogenic variant in ATP1A3.
    Parfyonov M; Ivaniuk A; Parikh S; Pestana-Knight E
    Epileptic Disord; 2023 Aug; 25(4):545-548. PubMed ID: 37293976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain.
    Bøttger P; Tracz Z; Heuck A; Nissen P; Romero-Ramos M; Lykke-Hartmann K
    J Comp Neurol; 2011 Feb; 519(2):376-404. PubMed ID: 21165980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATP1A3-related disorders in the differential diagnosis of acute brainstem and cerebellar dysfunction.
    Duat-Rodríguez A; Prochazkova M; Sebastian IP; Extremera VC; Legido MJ; Palero SR; Ortiz Cabrera NV
    Eur J Paediatr Neurol; 2021 Sep; 34():105-109. PubMed ID: 34464766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal Models.
    Holm TH; Lykke-Hartmann K
    Front Physiol; 2016; 7():209. PubMed ID: 27378932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.
    Vetro A; Nielsen HN; Holm R; Hevner RF; Parrini E; Powis Z; Møller RS; Bellan C; Simonati A; Lesca G; Helbig KL; Palmer EE; Mei D; Ballardini E; Van Haeringen A; Syrbe S; Leuzzi V; Cioni G; Curry CJ; Costain G; Santucci M; Chong K; Mancini GMS; Clayton-Smith J; Bigoni S; Scheffer IE; Dobyns WB; Vilsen B; Guerrini R;
    Brain; 2021 Jun; 144(5):1435-1450. PubMed ID: 33880529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetically altered animal models for ATP1A3-related disorders.
    Ng HWY; Ogbeta JA; Clapcote SJ
    Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34612482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive impairment in rapid-onset dystonia-parkinsonism.
    Cook JF; Hill DF; Snively BM; Boggs N; Suerken CK; Haq I; Stacy M; McCall WV; Ozelius LJ; Sweadner KJ; Brashear A
    Mov Disord; 2014 Mar; 29(3):344-50. PubMed ID: 24436111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The expanding clinical and genetic spectrum of ATP1A3-related disorders.
    Rosewich H; Ohlenbusch A; Huppke P; Schlotawa L; Baethmann M; Carrilho I; Fiori S; Lourenço CM; Sawyer S; Steinfeld R; Gärtner J; Brockmann K
    Neurology; 2014 Mar; 82(11):945-55. PubMed ID: 24523486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced inhibitory neurotransmission in the cerebellar cortex of Atp1a3-deficient heterozygous mice.
    Ikeda K; Satake S; Onaka T; Sugimoto H; Takeda N; Imoto K; Kawakami K
    J Physiol; 2013 Jul; 591(13):3433-49. PubMed ID: 23652595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variants in the ATP1A3 Gene Mutations within Severe Apnea Starting in Early Infancy: An Observational Study of Two Cases with a Possible Relation to Epileptic Activity.
    Holze N; Baalen AV; Stephani U; Helbig I; Muhle H
    Neuropediatrics; 2018 Oct; 49(5):342-346. PubMed ID: 29801192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epileptic encephalopathy with features of rapid-onset dystonia Parkinsonism and alternating hemiplegia of childhood: a novel combination phenotype associated with ATP1A3 mutation.
    Tran L; Richards J; McDonald M; McConkie-Rosell A; Stong N; Jasien J; Shashi V; Mikati MA
    Epileptic Disord; 2020 Feb; 22(1):103-109. PubMed ID: 32043468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism.
    Barbano RL; Hill DF; Snively BM; Light LS; Boggs N; McCall WV; Stacy M; Ozelius L; Sweadner KJ; Brashear A
    Parkinsonism Relat Disord; 2012 Jul; 18(6):737-41. PubMed ID: 22534615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A de novo p.Arg756Cys mutation in ATP1A3 causes a distinct phenotype with prolonged weakness and encephalopathy triggered by fever.
    Nakamura Y; Hattori A; Nakashima M; Ieda D; Hori I; Negishi Y; Ando N; Matsumoto N; Saitoh S
    Brain Dev; 2018 Mar; 40(3):222-225. PubMed ID: 29066118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychiatric disorders in rapid-onset dystonia-parkinsonism.
    Brashear A; Cook JF; Hill DF; Amponsah A; Snively BM; Light L; Boggs N; Suerken CK; Stacy M; Ozelius L; Sweadner KJ; McCall WV
    Neurology; 2012 Sep; 79(11):1168-73. PubMed ID: 22933743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3.
    Sabouraud P; Riquet A; Spitz MA; Deiva K; Nevsimalova S; Mignot C; Lesca G; Bednarek N; Doummar D; Pietrement C; Laugel V
    Eur J Paediatr Neurol; 2019 May; 23(3):448-455. PubMed ID: 30862413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation.
    Yano ST; Silver K; Young R; DeBrosse SD; Ebel RS; Swoboda KJ; Acsadi G
    Pediatr Neurol; 2017 Aug; 73():101-105. PubMed ID: 28647130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneity of presentation and outcome in the Irish rapid-onset dystonia-parkinsonism kindred.
    McKeon A; Ozelius LJ; Hardiman O; Greenway MJ; Pittock SJ
    Mov Disord; 2007 Jul; 22(9):1325-7. PubMed ID: 17516473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive deficits caused by a disease-mutation in the α3 Na(+)/K(+)-ATPase isoform.
    Holm TH; Isaksen TJ; Glerup S; Heuck A; Bøttger P; Füchtbauer EM; Nedergaard S; Nyengaard JR; Andreasen M; Nissen P; Lykke-Hartmann K
    Sci Rep; 2016 Aug; 6():31972. PubMed ID: 27549929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The rapid-onset dystonia parkinsonism mutation D923N of the Na+, K+-ATPase alpha3 isoform disrupts Na+ interaction at the third Na+ site.
    Einholm AP; Toustrup-Jensen MS; Holm R; Andersen JP; Vilsen B
    J Biol Chem; 2010 Aug; 285(34):26245-54. PubMed ID: 20576601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Phenotypic Continuum of
    Vezyroglou A; Akilapa R; Barwick K; Koene S; Brownstein CA; Holder-Espinasse M; Fry AE; Németh AH; Tofaris GK; Hay E; Hughes I; Mansour S; Mordekar SR; Splitt M; Turnpenny PD; Demetriou D; Koopmann TT; Ruivenkamp CAL; Agrawal PB; Carr L; Clowes V; Ghali N; Holder SE; Radley J; Male A; Sisodiya SM; Kurian MA; Cross JH; Balasubramanian M
    Neurology; 2022 Oct; 99(14):e1511-e1526. PubMed ID: 36192182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.